For instance, a systematic review and meta-analysis by Lai et al. (2024) [29] highlighted the importance of considering sex, line of therapy, cancer subtype, and PD-L1 status when assessing the risk versus benefit of ICIs. This evidence concerns the gene CD274 and cancer.